↓ Skip to main content

Temozolomide for high grade glioma

Overview of attention for article published in Cochrane database of systematic reviews, April 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

news
2 news outlets
facebook
1 Facebook page
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
236 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Temozolomide for high grade glioma
Published in
Cochrane database of systematic reviews, April 2013
DOI 10.1002/14651858.cd007415.pub2
Pubmed ID
Authors

Michael G Hart, Ruth Garside, Gabriel Rogers, Ken Stein, Robin Grant

Abstract

High grade glioma (HGG) is an aggressive form of brain cancer. Treatment of HGG usually entails biopsy, or resection if safe, followed by radiotherapy. Temozolomide is a novel oral chemotherapy drug that penetrates into the brain and purportedly has a low incidence of adverse events.

Mendeley readers

The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 <1%
France 1 <1%
Netherlands 1 <1%
Germany 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 229 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 20%
Student > Bachelor 31 13%
Student > Ph. D. Student 31 13%
Researcher 28 12%
Student > Doctoral Student 27 11%
Other 49 21%
Unknown 22 9%
Readers by discipline Count As %
Medicine and Dentistry 107 45%
Agricultural and Biological Sciences 24 10%
Biochemistry, Genetics and Molecular Biology 17 7%
Nursing and Health Professions 11 5%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Other 34 14%
Unknown 34 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2017.
All research outputs
#935,075
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#2,798
of 8,923 outputs
Outputs of similar age
#13,628
of 155,667 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 116 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,667 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.